Description
The G6PD Deficiency Website offers this app in both English and Italian to its donors and healthcare professionals.
The App allows you to view and search drugs that are contraindicated to G6PD Deficient patients, as well as drugs that are of low-risk to such patients.
The App allows you to view and search drugs that are contraindicated to G6PD Deficient patients, as well as drugs that are of low-risk to such patients.
Screenshots
G6PD Drug Search FAQ
-
Is G6PD Drug Search free?
Yes, G6PD Drug Search is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is G6PD Drug Search legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does G6PD Drug Search cost?
G6PD Drug Search is free.
-
What is G6PD Drug Search revenue?
To get estimated revenue of G6PD Drug Search app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
5 out of 5
3 ratings in China
5 star
3
4 star
0
3 star
0
2 star
0
1 star
0
Ratings History
G6PD Drug Search Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Free
|
|
343
|
Farmaci Favismo Installs
Last 30 days
Farmaci Favismo Revenue
Last 30 daysG6PD Drug Search Revenue and Downloads
Gain valuable insights into Farmaci Favismo performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Alexander Zass
- Languages
- English
- Recent release
- 1.2.3 (8 months ago )
- Released on
- Sep 13, 2018 (6 years ago )
- Also available in
- Italy, United States, China, Thailand, Philippines, Pakistan, Saudi Arabia, Singapore, Switzerland, United Arab Emirates, Austria, Lebanon, Kuwait, Mexico, South Korea, Malaysia, Netherlands, Norway, New Zealand, Romania, Peru, Poland, Portugal, Israel, Russia, Sweden, Türkiye, Taiwan, Ukraine, Vietnam, South Africa, Dominican Republic, Argentina, Australia, Azerbaijan, Belgium, Brazil, Belarus, Canada, Chile, Colombia, Czechia, Germany, Denmark, Japan, Algeria, Ecuador, Egypt, Spain, Finland, France, United Kingdom, Greece, Hong Kong SAR China, Indonesia, Ireland, India
- Last Updated
- 1 day ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.